Christopher McGuigan

1.8k total citations
58 papers, 900 citations indexed

About

Christopher McGuigan is a scholar working on Pathology and Forensic Medicine, Neurology and Psychiatry and Mental health. According to data from OpenAlex, Christopher McGuigan has authored 58 papers receiving a total of 900 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pathology and Forensic Medicine, 16 papers in Neurology and 10 papers in Psychiatry and Mental health. Recurrent topics in Christopher McGuigan's work include Multiple Sclerosis Research Studies (33 papers), Peripheral Neuropathies and Disorders (11 papers) and Polyomavirus and related diseases (6 papers). Christopher McGuigan is often cited by papers focused on Multiple Sclerosis Research Studies (33 papers), Peripheral Neuropathies and Disorders (11 papers) and Polyomavirus and related diseases (6 papers). Christopher McGuigan collaborates with scholars based in Ireland, United Kingdom and United States. Christopher McGuigan's co-authors include Michael Hutchinson, Niall Tubridy, Karen O’Connell, Cathal Walsh, Ronan P. Killeen, Catriona Kennedy, Marcia Finlayson, Susan Coote, Sara Hayes and Rose Galvin and has published in prestigious journals such as Neurology, Cancer Research and Cochrane Database of Systematic Reviews.

In The Last Decade

Christopher McGuigan

56 papers receiving 871 citations

Peers

Countries citing papers authored by Christopher McGuigan

Since Specialization

Citations

This map shows the geographic impact of Christopher McGuigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher McGuigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher McGuigan more than expected).

Fields of papers citing papers by Christopher McGuigan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher McGuigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher McGuigan. The network helps show where Christopher McGuigan may publish in the future.

Co-authorship network of co-authors of Christopher McGuigan

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher McGuigan. A scholar is included among the top collaborators of Christopher McGuigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher McGuigan. Christopher McGuigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A complex and severe encephalitis associated with four co-existing neuronal cell-surface autoantibodies 2024 ·Journal of Neuroimmunology ·(unknown), Luke O’Donnell, (unknown), Niall Tubridy, (unknown), Christopher McGuigan, Seán Connolly, Michael J. Farrell, Patrick Waters, Sarosh R. Irani, Justin Kinsella	0
2	Autoimmune central nervous system disorders: Antibody testing and its clinical utility 2024 ·Clinical Biochemistry ·(unknown), Christopher McGuigan, Andrew McKeon	10
3	Premorbid cognitive functioning influences differences between self‐reported cognitive difficulties and cognitive assessment in multiple sclerosis 2023 ·Journal of Neuropsychology ·(unknown), Fiadhnait O’Keeffe, (unknown), Niall Tubridy, (unknown), Christopher McGuigan, Jessica Bramham	4
4	What would improve MS clinic services for cognition? – A stakeholder panel and survey exploration 2022 ·Multiple Sclerosis and Related Disorders ·Dawn Langdon, (unknown), Christopher McGuigan, Brian Morrow, Guy Peryer, Carolyn Young	2
5	Postural stability is a valid and meaningful disability metric in progressive MS with potential for use in neuroprotective therapy trials 2021 ·Multiple Sclerosis and Related Disorders ·(unknown), (unknown), (unknown), (unknown), Hugh Kearney, Niall Tubridy, Richard B. Reilly, Christopher McGuigan	5
6	Vaccine hesitancy among people with multiple sclerosis 2021 ·Multiple Sclerosis and Related Disorders ·(unknown), (unknown), (unknown), Ian Callanan, Hugh Kearney, Niall Tubridy, Christopher McGuigan	23
7	Five-year follow up of the original Irish BICAMS validation cohort 2021 ·Multiple Sclerosis and Related Disorders ·(unknown), (unknown), Karen O’Connell, (unknown), (unknown), Niall Tubridy, Fiadhnait O’Keeffe, Christopher McGuigan	7
8	Moyamoya disease and moyamoya syndrome in Ireland: patient demographics, mode of presentation and outcomes of EC-IC bypass surgery 2020 ·Irish Journal of Medical Science (1971 -) ·(unknown), John Caird, Darach Crimmins, Peter J. Kelly, Séan Murphy, Christopher McGuigan, Niall Tubridy, Mary D. King, Bryan Lynch, David Webb, Desmond O’Neill, Dominick J. H. McCabe, Peter Boers, Mary O’Regan, Joan T. Moroney, David Williams, Simon Cronin, Mohsen Javadpour	7
9	Dimethyl fumarate modulates the Treg–Th17 cell axis in patients with psoriasis* 2020 ·British Journal of Dermatology ·(unknown), Deborah Cluxton, (unknown), Andreea Petrasca, (unknown), Barry Moran, Cheryl Sweeney, Anna Malara, (unknown), Christopher McGuigan, Brian Kirby, Jean M. Fletcher	24
10	Pharmacovigilance during treatment of multiple sclerosis: early recognition of CNS complications 2020 ·Journal of Neurology Neurosurgery & Psychiatry ·Martijn T. Wijburg, Clemens Warnke, Christopher McGuigan, Igor J. Koralnik, Frederik Barkhof, Joep Killestein, Mike P. Wattjes	9
11	An International Registry Tracking Pregnancy Outcomes in Women Treated with Dimethyl Fumarate (1003) 2020 ·Neurology ·Kerstin Hellwig, David Rog, Christopher McGuigan, Kun Chen, Becky Parks, Cynthia C. Jones	4
12	Rash developing after cessation of Daclizumab for relapsing remitting MS; a case series 2019 ·Multiple Sclerosis and Related Disorders ·Andrew Lockhart, Brian Kirby, Christopher McGuigan	2
13	MRI and multiple sclerosis––the evolving role of MRI in the diagnosis and management of MS: the radiologist’s perspective 2017 ·Irish Journal of Medical Science (1971 -) ·(unknown), Hugh Kearney, Yvonne Purcell, Christopher McGuigan, Ronan P. Killeen	7
14	FDG PET diagnosis of primary intracranial lymphoma: Radiology-Pathology correlation 2017 ·QJM ·(unknown), Gerard M. Healy, Ciaran E. Redmond, Michael Farrell, (unknown), Christopher McGuigan, Ronan P. Killeen	1
15	Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study 2017 ·Multiple Sclerosis and Related Disorders ·Karen O’Connell, Niall Tubridy, Michael Hutchinson, Christopher McGuigan	24
16	MRI and multiple sclerosis—the evolving role of MRI in the diagnosis and management of MS: a clinician’s perspective 2017 ·Irish Journal of Medical Science (1971 -) ·Hugh Kearney, (unknown), Ronan P. Killeen, Christopher McGuigan	3
17	Direct and Indirect Economic Consequences of Multiple Sclerosis in Ireland 2014 ·Applied Health Economics and Health Policy ·(unknown), Cathal Walsh, Christopher McGuigan, Niall Tubridy, Michael Barry	24
18	Population frequency of HLA haplotypes contributes to the prevalence difference of multiple sclerosis in Ireland 2005 ·Journal of Neurology ·Christopher McGuigan, Cara Dunne, John P. Crowley, Richard Hagan, (unknown), E. Lawlor, Michael Hutchinson	14
19	The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure. 2004 ·PubMed ·Christopher McGuigan, Michael Hutchinson	123
20	Severe illness and death among injecting drug users in Scotland: a case-control study 2004 ·Epidemiology and Infection ·Allen Taylor, Sharon Hutchinson, Jairam R. Lingappa, Sarah Wadd, S. Faisal Ahmed, Laurence Gruer, Thomas H. Taylor, Koyel Roy, Gail Gilchrist, Christopher McGuigan, G. Penrice, David Goldberg	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact